Abstract:Enhancing neuronal α7 nicotinic acetylcholine receptor (α7 nAChR) function can alleviate cognitive deficits. Here, we report the design, synthesis, and evaluation of N-(4-(trifluoromethoxy)phenyl)-1,3,5-triazin-2-amine derivatives 8–10 as a series of novel α7 nAChR positive allosteric modulators (PAMs). The representative compound 10e functions as a type I PAM with an EC50 of 3.0 μM and approximately 38-fold enhancement of α7 current in the presence of agonist acetylcholine (100 μM). It specifically enhances α7 current with high selectivity. Compound 10e shows good pharmacokinetic property in mice. Intraperitoneal injection of 10e (3 mg/kg) exhibits sufficient blood–brain barrier penetration in mice. Furthermore, 10e can also rescue the auditory gating deficit in mice with schizophrenia-like behavior. Molecular docking of 10e with homopentameric α7 nAChR reveals a new mode of action. These results support the potential of 10e for treatment for schizophrenia and Alzheimer's disease.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01058.Rat liver microsome stability assessment of test compounds; Individual concentrations of 9d in rats dosed by IV at 1 mg/kg; Individual concentrations of 9d in rats dosed by PO at 10 mg/kg; Individual concentrations of 10d in mice dosed by IV at 1 mg/kg and PO/IP at 3 mg/kg; Individual concentrations of 10e in mice dosed by IV at 1 mg/kg and PO/IP at 3 mg/kg; Selective increase on other subtypes by compound 8l, 9d, and 10e instead of α7 nAChR current; Mean concentrations of 10e in plasma and brain; NMR spectra, HPLC reports and HRMS of the target compounds 8–10 (PDF)PAINS filter using False Positive Remover (PDF)Molecular formula strings of the target compounds (CSV)Docking results of compound 5b with modeled human alpha 7 nAChR (PDB)Docking results of compound 10e with modeled human alpha 7 nAChR (PDB)This article has not yet been cited by other publications.

Early Process Development and Scale-Up of a Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor

Development of a Scalable Synthesis of Mevidalen (LY3154207), an Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

Development of Palladium-Catalyzed Suzuki Carbonylation Reaction Without External Ligand and Its Application in Modification of Novel Series of Α7 Nachr PAMs

Optimization and Development of a Scalable Palladium-Catalyzed C–H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator

Early Process Development of CH7057288, a Benzofuran-Containing Selective NTRK Inhibitor

Synthesis and Biological Evaluation of Novel Triazine Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors

Sonogashira coupling reaction in the synthesis of novel positive allosteric modulators of α7 nicotinic acetylcholine receptors

Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid Through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C–N Coupling

Process Development of a Macrocyclic Peptide Inhibitor of PD-L1

Chemical Conversion of Nicotinamide into Type I Positive Allosteric Modulator of Α7 Nachrs.

Design and Synthesis of Novel Positive Allosteric Modulators of Α7 Nicotinic Acetylcholine Receptors with the Ability to Rescue Auditory Gating Deficit in Mice.

Design, synthesis and evaluation of novel 2-phenyl-3-(1 H -pyrazol-4-yl)pyridine positive allosteric modulators for the M 4 mAChR

Building a Quaternary Stereogenic Center on Dihydroazaindole Carboxylic Acid through Scalable Process Development

Allosteric Activation of α7 Nicotinic Acetylcholine Receptors by Novel 2-Arylamino-thiazole-5-carboxylic Acid Amide Derivatives for the Improvement of Cognitive Deficits in Mice

Process Development and Manufacture of the Core Starting Material of Adagrasib (MRTX849)

Metal-Catalyzed C–N Bond Forming Reaction Selection and Process Development for the Manufacture of AZD7594

Process Development of a Novel Route to Rilpivirine Hydrochloride

Novel Positive Allosteric Modulators of the Human Α7 Nicotinic Acetylcholine Receptor

Exploration of Synthetic Approaches and Pharmacological Evaluation of PNU-69176E and Its Stereoisomer As 5-HT2C Receptor Allosteric Modulators.

Discovery of VU6007496: Challenges in the Development of an M1 Positive Allosteric Modulator Backup Candidate